RankAlpha logo
Back to Rankings

CVKD

Cadrenal TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CVKD vs peer average
28/100
CVKD vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PMCB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.55M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPMCBPharmaCyte Biotech
CVKD
Cadrenal Therapeutics
PMCB
PharmaCyte Biotech
Grade
F
D
Momentum
9
19
Value
41
60
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs PMCB

CVKD / PMCB
Grade Position
Below peers
CVKD vs. peer average (F vs. D)
28/100
Momentum
9
PMCB
Value
41
PMCB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CVKD
1
PMCB
PharmaCyte Biotech Inc Common
D
40/100
-1
2
ACXP
Acurx Pharmaceuticals Inc Common
D
40/100
-1
3
GELS
Gelteq Ltd Common
D
40/100
-1
4
EVGN
Evogene Ltd Common
D
40/100
-1
5
ADXN
Addex Therapeutics Ltd ADR
F
20/100
Even
PMCB is the first peer returned for this comparison set.